Clinical Trials Browser

Terminated × INDUSTRY × tagraxofusp × Clear all

NCT02270463 2024-10-17

SL-401 as Consolidation Therapy in Patients With Adverse Risk Acute Myeloid Leukemia in First Complete Remission

Phase 1/2 Terminated

16 enrolled 14 charts

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT02661022 2024-04-17

SL-401 in Combination With Pomalidomide and Dexamethasone in Relapsed or Relapsed and Refractory Multiple Myeloma

Phase 1/2 Terminated

9 enrolled 13 charts

Multiple Myeloma, Recurrence